BioCentury
ARTICLE | Strategy

Amortizing exploitable technology

July 31, 1995 7:00 AM UTC

Noteworthy

The benefits of exploiting an enabling technology that can be sold more than once are apparent in Alkermes Inc.'s strategy in developing its ProLease peptide drug delivery technology. ...